XOMA Corp (XOMA)

18.25 -0.38  -2.04% NASDAQ Jul 16, 09:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/06/2020 Earnings XOMA Corp Second Quarter Earnings Results in 2020
05/20/2020 09:00 PDT Misc XOMA Corp Annual General Meeting for 2019
05/05/2020 Earnings XOMA Corp First Quarter Earnings Results for 2020
03/10/2020 Earnings XOMA Corp Fourth Quarter Earnings Results for 2019
03/10/2020 Misc XOMA Corp Annual Report for 2019
11/05/2019 Earnings XOMA Corp Third Quarter Earnings Results for 2019
08/06/2019 Earnings XOMA Corp Second Quarter Earnings Results in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.xoma.com
  • Investor Relations URL: http://investors.xoma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 06, 2020
  • Last Earnings Release: May. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. Its proprietary product candidates are X358, X213, X129, and Gevokizumab. The business operations of the company are functioned through the United States, Europe, and the Asia Pacific. XOMA's primary source of revenue is from license and collaboration arrangements, contract services, and royalties and the majority of the revenue is generated from the United States.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.